Compare
5 stocks, side by sideRelative performance · rebased to 100
TLXCRNXNAMSRCUSELVN
| TLXTelix Pharmaceuticals Limited | CRNXCrinetics Pharmaceuticals, Inc. | NAMSNewAmsterdam Pharma Company N.V. | RCUSArcus Biosciences, Inc. | ELVNEnliven Therapeutics, Inc. | |
|---|---|---|---|---|---|
| Smart Score | - | 4/10 | 3/10 | 8/10 | 10/10 |
| Price | $10.86 | $34.99 | $31.73 | $30.25 | $49.12 |
| 1 month | +13% | -4.9% | -12% | +25% | +15% |
| 1 year | -34% | +13% | +72% | +246% | +132% |
| 5 year | - | +81% | +225% | +27% | +61% |
| P/E (TTM) | - | -7.4 | -17.4 | -10.3 | -35.5 |
| P/E vs sector | - | - | - | - | - |
| Market cap | $3.7B | $3.7B | $3.7B | $3.8B | $3.5B |
| Sector | Healthcare | Healthcare | Healthcare | Healthcare | Healthcare |
Risk / Return · past yearAnnualized return vs volatility, up-and-left is more reward for less risk.
Correlation · do they move together?Pairwise daily-return correlation over the past year, high = one bet, low = diversifying.